Amino acid residues 196-225 of LcrV represent a plague protective epitope

Vaccine

Volumn 28, Issue 7, 2010, Pages 1870-1876

  Quenee, Lauriane E ^a   Berube, Bryan J ^a   Segal, Joshua ^a   Elli, Derek ^a   Ciletti, Nancy A ^a   Anderson, Deborah ^a   Schneewind, Olaf ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

LcrV; Monoclonal antibody; Plague; Protective epitope; Type III secretion

Indexed keywords

EPITOPE; LCRV ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BA5; NEUTRALIZING ANTIBODY; PLAGUE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY SCREENING; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PLAGUE; PRIORITY JOURNAL; PROTECTION; TYPE III SECRETION SYSTEM; YERSINIA PESTIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGENS, BACTERIAL; EPITOPE MAPPING; EPITOPES; FEMALE; HELA CELLS; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS;

EID: 75249085252     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.11.076     Document Type: Article

References (48)

1. Yersin A. La peste bubonique à Hong-Kong. Ann Inst Pasteur 2 (1894) 428-430
2. Cornelis G.R., Boland A., Boyd A.P., Geuijen C., Iriarte M., Neyt C., et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 62 (1998) 1315-1352
3. Rosqvist R., Magnusson K.-E., and Wolf-Watz H. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J 13 (1994) 964-972
4. Nakajima R., Motin V.L., and Brubaker R.R. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 63 (1995) 3021-3029
5. Rosqvist R., Bolin I., and Wolf-Watz H. Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involved in the Yop2b protein. Infect Immun 56 (1988) 2139-2143
6. Lee V.T., Anderson D.M., and Schneewind O. Targeting of Yersinia Yop proteins into the cytosol of HeLa cells: one-step translocation of YopE across bacterial and eukaryotic membranes is dependent on SycE chaperone. Mol Microbiol 28 (1998) 593-601
7. Viboud G.I., and Bliska J.B. A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes. EMBO J 20 (2001) 5373-5382
8. Marketon M.M., DePaolo R.W., DeBord K.L., Jabri B., and Schneewind O. Plague bacteria target immune cells during infection. Science 309 (2005) 1739-1741
9. 2+ response operon encodes the V antigen of Yersinia pestis. Infect Immun 54 (1986) 428-434
10. Mueller C.A., Broz P., Muller S.A., Ringler P., Erne-Brand F., Sorg I., et al. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310 (2005) 674-676
11. Fields K.A., Nilles M.L., Cowan C., and Straley S.C. Virulence role of V antigen of Yersinia pestis at the bacterial surface. Infect Immun 67 (1999) 5395-5408
12. Petterson J., Holmstrom A., Hill J., Frithz-Lindsten E., von Euler-Matell A., Carlsson E., et al. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 32 (1999) 961-976
13. Lee V.T., Tam C., and Schneewind O. LcrV, a substrate for Yersinia enterocolitica type III secretion, is required for toxin targeting into the cytosol of HeLa cells. J Biol Chem 275 (2000) 36869-36875
14. Hakansson S., Bergman T., Vanooteghem J.-C., Cornelis G., and Wolf-Watz H. YopB and YopD constitute a novel class of Yersinia Yop proteins. Infect Immun 61 (1993) 71-80
15. Hakansson S., Schesser K., Persson C., Galyov E.E., Rosqvist R., Homble F., et al. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J 15 (1996) 5812-5823
16. Mueller C.A., Broz P., and Cornelis G.R. The type III secretion system tip complex and translocon. Mol Microbiol 68 (2008) 1085-1095
17. Burrows T.W. An antigen determining virulence in Pasteurella pestis. Nature 177 (1956) 426-427
18. Burrows T.W. Virulence of Pasteurella pestis. Nature 179 (1957) 1246-1247
19. Burrows T.W., and Bacon G.A. The effect of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Br J Exp Pathol 39 (1958) 278-291
20. Une T., and Brubaker R.R. Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol 133 (1984) 2226-2230
21. Motin V.M., Nedialkov Y.A., and Brubaker R.R. V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague. Infect Immun 64 (1996) 4313-4318
22. Leary S.E.C., Williamson E.D., Griffin K.F., Russell P., Eley S.M., and Titball R.W. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun 63 (1995) 2854-2858
23. Cornelius C.A., Quenee L.E., Elli D., Ciletti N.A., and Schneewind O. V10 subunit vaccine protects cynomolgus macaques from lethal pneumonic plague. Infect Immun 76 (2008) 5588-5597
24. Motin V.L., Nakajima R., Smirvov G.B., and Brubaker R.R. Passive immunity to yersiniae mediated by anti-recombinant V antigen and Protein A-V antigen fusion peptide. Infect Immun 62 (1994) 4192-4201
25. Williamson E.D., Flick-Smith H.C., Waters E., Miller J., Hodgson I., Le Butt C.S., et al. Immunogenicity of the rF1 + rV vaccine for plague with identification of potential immune correlates. Microb Pathogen 42 (2007) 11-21
26. Hill J., Leary S.E.C., Griffin K., Williamson E.D., and Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 65 (1997) 4476-4482
27. Parent M.A., Berggren K.N., Mullarky I.K., Szaba F.M., Kummer L.W., Adamovicz J.J., et al. Yersinia pestis V protein epitopes recognized by CD4 T cells. Infect Immun 73 (2005) 2197-2204
28. Weeks S., Hill J., Friedlander A., and Welkos S. Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb Pathogen 32 (2002) 227-237
29. Hill J., Copse C., Leary S., Stagg A.J., Williamson E.D., and Titball R.W. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersina pestis. Infect Immun 71 (2003) 2234-2238
30. Derewenda U., Mateja A., Devedjiev Y., Routzahn K.M., Evdokimov A.G., Derewenda Z.S., et al. The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure 12 (2004) 301-306
31. Vernazza C., Lingard B., Flick-Smith H.C., Baillie L.W.J., Hill J., and Atkins H.S. Small protective fragments of the Yersinia pestis V antigen. Vaccine 27 (2009) 2775-2780
32. Smiley S.T. Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines 7 (2008) 209-221
33. Brubaker R.R. Interleukin-10 and the inhibition of innate immunity to yersiniae: roles of Yops and LcrV (V antigen). Infect Immun (2003) 3673-3681
34. Overheim K.A., Depaolo R.W., Debord K.L., Morrin E.M., Anderson D.M., Green N.M., et al. LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 73 (2005) 5152-5159
35. Brubaker R.R. Mutation rate to non-pigmentation in Pasteurella pestis. J Bacteriol 98 (1969) 1404-1406
36. Deng W., Burland V., Plunkett Gr, Boutin A., Mayhew G.F., Liss P., et al. Genome sequence of Yersinia pestis KIM. J Bacteriol 184 (2002) 4601-4611
37. Parkhill J., Wren B.W., Thompson N.R., Titball R.W., Holden M.T., Prentice M.B., et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413 (2001) 523-527
38. DeBord K.L., Anderson D.M., Marketon M.M., Overheim K.A., DePaolo R.W., Ciletti N.A., et al. Immunogenicity and protective immunity against bubonic and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 74 (2006) 4910-4914
39. Sorg J.A., Miller N.C., Marketon M.M., and Schneewind O. Rejection of impassable substrates by Yersinia type III secretion machines. J Bacteriol 187 (2005) 7090-7102
40. Quenee L., Cornelius C.A., Ciletti N.A., Elli D., and Schneewind O. Yersinia pestis caf1 (F1) variants and the limits of plague vaccine protection. Infect Immun 76 (2008) 2025-2036
41. Torruellas J., Jackson M.W., Pennock J.W., and Plano G.V. The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion. Mol Microbiol 57 (2005) 1719-1733
42. Ferracci F., Schubot F.D., Waugh D.S., and Plano G.V. Selection and characterization of Yersinia pestis YopN mutants that constitutively block Yop secretion. Mol Microbiol 57 (2005) 970-987
43. Cheng L.W., Kay O., and Schneewind O. Regulated secretion of YopN by the type III machinery of Yersinia enterocolitica. J Bacteriol 183 (2001) 5293-5301
44. Lee V.T., Mazmanian S.K., and Schneewind O. A program of Yersinia enterocolitica type III secretion reactions is triggered by specific host signals. J Bacteriol 183 (2001) 4970-4978
45. Broz P., Mueller C.A., Muller S.A., Phillipsen A., Sorg I., Engel A., et al. Function and molecular architecture of the Yersinia injectisome tip complex. Mol Microbiol 65 (2007) 1311-1320
46. DePaolo R.W., Tang F., Kim I.Y., Han M., Levine N., Ciletti N.A., et al. TLR6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 4 (2008) 350-361
47. Bashaw J., Norris S., Weeks S., Trevino S., Adamovicz J.J., and Welkos S. Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin Vaccine Immunol 14 (2007) 605-616
48. Williamson E.D., Flick-Smith H.C., LeButt C., Rowland C.A., Jones S.M., Waters E.L., et al. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun 73 (2005) 3598-3608